NASDAQ : AARD

Aardvark Therapeutics, Inc. Common Stock

$6.33 USD

-$0.34 (-5.1%)

Volume
4.1K
Average Volume
270.89K
Market Capitalization
$138.53M
P/E Ratio
-2.05
Dividend Yield
0.00%
Price Target
$4.50
Year High
$17.94
Year Low
$3.35
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$8.06

NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)

19

NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)

6

AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)

$364.64K

AARD Estimated and Actual Revenue by Quarter

Get MSFT Insider Trade Alerts

AARD Insider Trading History

Insider Name Title Date Transaction Cost Filing Date
Sun Nelson officer: Chief Financial Officer 2026-02-09 A-Award 13.48 2026-02-11
Jaiman Manasi officer: Chief Medical Officer 2026-02-09 A-Award 13.48 2026-02-11
Lee Tien-Li director, 10 percent owner, officer: Chief Executive Officer 2026-02-09 A-Award 13.48 2026-02-11
Sun Nelson officer: Chief Financial Officer 2025-12-11 P-Purchase 14.4 2025-12-12
Lee Tien-Li director, 10 percent owner, officer: Chief Executive Officer 2025-12-11 P-Purchase 14.485 2025-12-12
Lee Tien-Li director, 10 percent owner, officer: Chief Executive Officer 2025-10-15 M-Exempt 4.24 2025-10-16
Lee Tien-Li director, 10 percent owner, officer: Chief Executive Officer 2025-10-15 M-Exempt 4.24 2025-10-16
Jones Bryan officer: Chief Operating Officer 2025-10-15 M-Exempt 4.24 2025-10-16
Jones Bryan officer: Chief Operating Officer 2025-10-15 M-Exempt 4.24 2025-10-16
Lee Tien-Li director, 10 percent owner, officer: Chief Executive Officer 2025-09-15 P-Purchase 9.9442 2025-09-16
Lee Tien-Li director, 10 percent owner, officer: Chief Executive Officer 2025-09-15 P-Purchase 9.5106 2025-09-16
Lee Tien-Li director, 10 percent owner, officer: Chief Executive Officer 2025-09-12 P-Purchase 8.5031 2025-09-12
Lee Tien-Li director, 10 percent owner, officer: Chief Executive Officer 2025-09-11 P-Purchase 7.821 2025-09-12
Lee Tien-Li director, 10 percent owner, officer: Chief Executive Officer 2025-09-10 P-Purchase 7.9125 2025-09-12
Sun Nelson officer: Chief Financial Officer 2025-09-09 P-Purchase 8.0733 2025-09-10
Lee Tien-Li director, 10 percent owner, officer: Chief Executive Officer 2025-08-28 M-Exempt 4.24 2025-08-29
Lee Tien-Li director, 10 percent owner, officer: Chief Executive Officer 2025-08-28 M-Exempt 4.24 2025-08-29
Lee Tien-Li director, 10 percent owner, officer: Chief Executive Officer 2025-06-11 A-Award 11.29 2025-06-13
Chi Jeffrey director 2025-06-11 A-Award 11.29 2025-06-13
Jaiman Manasi officer: Chief Medical Officer 2025-06-11 A-Award 11.29 2025-06-13
Baynes Roy D. director 2025-06-11 A-Award 11.29 2025-06-13
Tong Victor Edward Jr director 2025-06-11 A-Award 11.29 2025-06-13
Sun Nelson officer: Chief Financial Officer 2025-06-11 A-Award 11.29 2025-06-13
Jones Bryan officer: Chief Operating Officer 2025-06-11 A-Award 11.29 2025-06-13
Graf Susan E director 2025-06-11 A-Award 11.29 2025-06-13
Creamer James W III officer: CFO & Treasurer 2007-08-17 P-Purchase 1.9 2007-08-23
Zimlich Joseph C director 2007-03-06 A-Award 2.75 2007-05-14
Creamer James W III officer: CFO & Treasurer 2006-11-08 P-Purchase 1.65 2007-03-23
Zimlich Joseph C director 2006-10-26 P-Purchase 3 2007-03-23
Zimlich Joseph C director 2006-12-06 P-Purchase 1.3 2006-12-11
Zimlich Joseph C director 2006-10-26 0 2006-11-06
Creamer James W III officer: Chief Financial Officer 2006-05-12 P-Purchase 3.05 2006-05-16
Creamer James W III officer 2006-05-03 0 2006-05-03